Zeng, T.; Li, F.; Yang, M.; Wu, Y.; Cui, W.; Mou, H.; Luo, X.
Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling. Biomedicines 2025, 13, 425.
https://doi.org/10.3390/biomedicines13020425
AMA Style
Zeng T, Li F, Yang M, Wu Y, Cui W, Mou H, Luo X.
Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling. Biomedicines. 2025; 13(2):425.
https://doi.org/10.3390/biomedicines13020425
Chicago/Turabian Style
Zeng, Ting, Fang Li, Min Yang, Yao Wu, Wei Cui, Huaming Mou, and Xiaohe Luo.
2025. "Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling" Biomedicines 13, no. 2: 425.
https://doi.org/10.3390/biomedicines13020425
APA Style
Zeng, T., Li, F., Yang, M., Wu, Y., Cui, W., Mou, H., & Luo, X.
(2025). Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling. Biomedicines, 13(2), 425.
https://doi.org/10.3390/biomedicines13020425
